Related Experiment Video
Updated: Nov 4, 2025
09:00
Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition
Published on: June 16, 2019
9.8K
Feeder-Free Differentiation Assay for Mouse Hematopoietic Stem and Progenitor Cells
Vincent Rondeau1, Marion Espéli2, Karl Balabanian3
1Université de Paris, Institut de Recherche Saint-Louis, EMiLy, INSERM U1160, Paris, France. vincent.rondeau@inserm.fr.
Methods in Molecular Biology (Clifton, N.J.)
|May 31, 2021
Summary
Researchers developed a new in vitro system to track hematopoietic stem cell (HSC) differentiation. This method quantifies HSCs becoming multipotent hematopoietic progenitors (MPPs) in a feeder-free culture, advancing regenerative medicine.
Area of Science:
- Hematology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Hematopoietic stem cells (HSCs) maintain immune cell populations within bone marrow niches.
- Ex vivo expansion of HSCs is crucial for regenerative medicine but faces significant challenges.
Purpose of the Study:
- To develop and validate an in vitro system for quantifying HSC differentiation.
- To enable accurate measurement of HSCs transitioning into multipotent hematopoietic progenitors (MPPs).
Main Methods:
- An original feeder-free in vitro culture system was established.
- Flow cytometry was utilized to quantify the differentiation of mouse HSCs into MPPs.
- Cytokine supplementation supported HSC maintenance and differentiation.
Main Results:
- The system successfully quantified the differentiation of HSCs into MPPs.
- Feeder-free culture with cytokines supported this specific differentiation pathway.
- This method provides a reliable tool for analyzing HSC behavior ex vivo.
Conclusions:
- The described in vitro system offers a robust method for studying HSC differentiation.
- This advancement facilitates research into HSC expansion for therapeutic applications.
- The system enables precise quantification of HSCs differentiating into MPPs.
